Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Briess Malt & Ingredients is a prominent North American producer of specialty malts and grain-based ingredients for the brewing, distilling, and food industries. Established in 1876, the company operates as a vertically integrated supplier, managing the process from seed to finished ingredient. Their product portfolio includes a diverse range of whole kernel malts, malt extracts, roasted grains, and gluten-free syrups. Briess serves a wide customer base ranging from small craft breweries to large-scale global food and beverage manufacturers. The company is recognized for its commitment to sustainability and non-GMO production standards across its multiple facilities in Wisconsin and Wyoming. Headquartered in Chilton, Wisconsin, Briess remains one of the few family-owned malting operations in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Briess Malt & Ingredients.